Intralesional Therapy · Recurrence Control · CityLink Mall
Removing a keloid is straightforward. Keeping it from coming back larger is the entire clinical difficulty — which is why excision alone reliably makes keloids worse, and why treatment here is a managed programme over months rather than a procedure with an end date.
A keloid is a wound-healing response that did not switch off. Fibroblasts recruited during the proliferative phase of repair continue producing collagen long past the point where remodelling should have replaced disorganised type III collagen with aligned type I and degraded the surplus. The result is a bulk of excess, poorly organised collagen that extends past the margin of the original injury into skin that was never damaged. The process is sustained by ongoing inflammatory signalling, and it behaves invasively rather than merely excessively.
Excision removes the bulk and leaves the mechanism entirely intact. Worse, the excision is itself a new wound — in a patient whose skin has already demonstrated exactly how it responds to wounding, in the same anatomical site, often under the same mechanical tension. The predictable outcome is recurrence, and because the new wound is larger than the original injury, the recurrent keloid is frequently larger than the one that was removed. This is not an occasional complication. Surgery alone, without adjunctive therapy, recurs in the large majority of cases.
Everything that genuinely works acts on the mechanism rather than the mass. Intralesional corticosteroid suppresses fibroblast proliferation and collagen synthesis and damps the inflammatory loop driving the whole process — it is the backbone of treatment and the reason most keloids soften, flatten and stop itching. Silicone and occlusion alter hydration at the stratum corneum, which appears to downregulate fibroblast signalling. Sustained pressure reduces mechanical load and local oxygen tension. Vascular laser targets the dense microvasculature feeding an active keloid.
Because each of these interrupts a different part of the loop, they are combined rather than chosen between. A realistic plan uses intralesional injection on a fixed interval, continuous silicone and pressure between visits, and laser where redness or texture warrants it — with surgery reserved for bulky or pedunculated lesions and always embedded inside that programme rather than substituted for it. The measure of success is not how the scar looks at eight weeks. It is whether it is still flat at two years.
Management
Keloids do not all present at the same point in their history, and what is appropriate depends heavily on whether the lesion is new, established, or being prevented in someone already known to form them. The three situations call for genuinely different plans.
Excision alone does not remove a keloid. It replaces one keloid with a larger one, and it does so reliably enough that it should not be offered on its own.
Realistic Expectations
The honest description of a good outcome is a scar that is flat or nearly flat, pale rather than red, soft rather than firm, and no longer itchy or tender — not a scar that has disappeared. The skin where a keloid sat has been permanently altered, and some mark will remain. Patients told to expect erasure are being set up to regard a genuinely good result as a failure. Symptom relief, incidentally, is often the change that matters most to the patient and it usually arrives before the appearance does.
Time horizons are long and this needs saying at the outset. Intralesional injections are given at intervals of several weeks over a course of months. Silicone is worn for months, daily, and its effectiveness is largely a function of whether it is actually used. Review continues beyond the first year because recurrence typically declares itself after treatment has stopped, not during it. Anyone offering a keloid solution in three sessions is describing the flattening, not the control.
There are boundaries worth stating. Scars that contract across a joint and restrict movement, very large or infected lesions, and keloids requiring complex reconstruction belong with a plastic surgeon, and Atelier Aesthetics will say so rather than attempting them. Depressed scarring is the opposite problem — too little collagen rather than too much — and is addressed through scar reconstruction using entirely different methods. Establishing which problem is in front of you is the first appointment, not an assumption.
Continue
Atelier Aesthetics · Owned by AYA
1 Raffles Link, #B1-28, CityLink Mall, Singapore 039393 · +65 8023 7170
Book a Consultation